A pilot program utilizing a vaccine against avian influenza is currently underway at a poultry farm. Following a positive test last year, this initiative is being conducted at a commercial poultry ...

The ASFV-G-ΔI177L vaccine is a modified-live African swine fever virus (ASFV) strain developed as a vaccination measure against African swine fever (ASF) in pigs. This vaccine strain was created by ...

A new study published in bioRxiv examines the pathogenicity and transmissibility of the bovine-derived HPAI H5N1 B3.13 virus in pigs. The HPAI H5N1 virus has been detected in dairy cattle, with ...

The outbreak caused substantial mortality among wild birds, poultry, and marine mammals and included one confirmed human case. A comprehensive surveillance effort was conducted, involving the ...

The primary poultry involved are commercial table egg layers, primarily due to the size of their flocks. However, when considering outbreak hotspots, most are found in turkey flocks. So, what should ...

A recent study published in ACS Sensors outlines the capabilities of a novel biosensor designed for the rapid detection of airborne avian influenza (H5N1) and Escherichia coli within a timeframe of ...

A field trial conducted at Wageningen University & Research (the Netherlands) evaluated the effectiveness of bird flu vaccines. The two experimental bird flu vaccines under investigation in this field ...

A newly published study in mBio investigates the characteristics of neuraminidase (NA) in clade 2.3.4.4b of the H5N1 avian influenza virus, highlighting the predominant presence of long-stalk variants ...

The National Chicken Council released the following statement after USDA announced federal actions to combat Highly Pathogenic Avian Influenza (HPAI). Attributable to NCC President Harrison Kircher: ...

The Trump administration is allocating up to $1 billion in new funding to mitigate the effects of highly pathogenic avian influenza (HPAI) and the resulting surge in egg prices. In an article ...

A new report published in MMWR found that between 2008 and 2022, cervical precancer incidence decreased by 79%, and higher-grade precancer incidence decreased by 80% among screened women aged 20–24 ...